Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice

Journal of Gastrointestinal and Liver Diseases

Volumn 20, Issue 4, 2011, Pages 355-358

  Naves, Juan E ^a   Lorenzo Zúñiga, Vicente ^a   Marín, Laura ^a   Mañosa, Míriam ^a   Oller, Blanca ^a   Moreno, Vicente ^a   Zabana, Yamile ^a   Boix, Jaume ^a   Cabré, Eduard ^a   Domènech, Eugeni ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Appendiceal; Outcomes; Prognosis; Treatment; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; MESALAZINE; STEROID;

ADULT; APPENDICITIS; ARTICLE; CLINICAL ARTICLE; DESCENDING COLON; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; PROCTITIS; SMOKING; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS; APPENDICITIS; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MESALAMINE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84055222301     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 (Suppl 4): 24-30.
2. Hendriksen C, Kreiner S, Blinder V. Long term prognosis in ulcerative colitis based on results from a regional patient group from the country of Copenhagen. Gut 1985; 26: 158-163.
3. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103:1444-1451.
4. Kjeldsen J. Treatment of ulcerative colitis with high doses of oral prednisolone. The rate of remission, the need for surgery, and the effectof prolonging the treatment. Scand J Gastroenterol 1993; 28: 821-826.
5. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-782.
6. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-250.
7. Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000; 95: 469-473.
8. Etchevers MJ, Aceituno M, García-Bosch O, et al. Risk factors and characteristics of extent progression in ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1320-1325.
9. Cohen T, Pfeffer RB, Valensi Q. "Ulcerative appendicitis" occurring as askip lesion in chronic ulcerative colitis; report of a case. Am J Gastroenterol 1974; 62: 151-155.
10. D'Haens G, Geboes K, Peeters M, Baert F, Ectors N, Rutgeerts P. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol 1997; 92: 1275-1279.
11. Matsumoto T, Nakamura S, Shimizu M, Iida M. Significance of appendiceal involvement in patients with ulcerative colitis. Gastrointest Endosc 2002; 55: 180-185.
12. Mutinga ML, Odze RD, Wang HH, Hornick JL, Farraye FA.The clinical significance of rightsided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis 2004; 10: 215-219.
13. Byeon JS, Yang SK, Myung SJ, et al. Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status. InflammBowel Dis 2005; 11: 366-371.
14. Rubin DT, Rothe JA. The peri-appendiceal red patch in ulcerative colitis: Review of the University of Chicago experience. Dig Dis Sci 2010; 55: 3495-3501.
15. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5-36.
16. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24 (Suppl 170): 2-6.
17. Koutroubakis IE, Vlachonikolis IG. Appendicectomy and development of ulcerative colitis: results of a meta-analysis of published case control studies. Am J Gastroenterol 2000; 95: 171-176.
18. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against Ulcerative Colitis. N Engl J Med 2001; 344: 808-814.
19. Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitisand Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22: 1009-1024.
20. Reif S, Lavy A, Keter D, et al. Appendectomy is more frequent but not arisk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 829-832.
21. Bolin TD, Wong S, Crouch R, Engelman JL, Riordan SM. Appendicectomy as a therapy for ulcerative proctitis. Am J Gastroenterol2009; 104: 2476-2482.
22. Yamagishi N, Iizuka B, Nakamura T, Hayashi N. Clinical and colonoscopic investigation of skipped periappendiceal lesions in ulcerative colitis. Scand J Gastroenterol 2002; 37: 177-182.